Stephen Petranek’s career of over 40 years in the publishing world is marked by numerous prizes and awards for excellent writing on science, nature, technology, politics, economics and more. He has been editor-in-chief of the Miami Herald’s prestigious Sunday magazine, Tropic, and has covered a wide range of topics for Time Inc.’s Life magazine. His presentation 10 Ways the World Could End is one of the most original and most watched TED talks of all time.
This tiny biotech stock has finally been approved its Phase 1/2a stem cell trial for Parkinson’s disease, and we are about to see the company’s future tested in real time.
Our immunology cancer stock is teaming up with another biotech company to create off-the-shelf allogeneic T-cell therapies that do not have to be customized to one person at a time.
It’s beginning to look like our local neighborhood has extraordinary opportunities. A new study used data from the Hubble telescope to estimate that there are hundreds of millions of habitable Earth-like planets within our own galaxy, the Milky Way. Stephen Petranek has more on why we may need to go planet shopping in the not-so-distant future.
Why is this tiny stock still in the portfolio? Have I lost my marbles? Perhaps. But the scientists in this company really understand their science and believe in it.
Two weeks ago in my monthly report, I noted that we needed to trim the portfolio. As part of that effort, I suggested selling this biotech position if and when it reached our initial buy-in price, and the time has come.
Sometimes the obvious is so easy to see that it makes you wonder what Wall Street insiders and analysts are reading over their morning joe. As I have repeatedly pointed out for months now, if you need a great rocket engine, you’ve got one phone call to make.
The nuclear power plant disaster in Fukushima, Japan nearly four years ago set off a tidal wave of plant closings around Europe. But it wasn’t enough to quash plans for new nukes in the United States. Stephen Petranek has more on the newest power plant opening in the Tennessee Valley, and the precautions engineers are taking to prevent a nuclear disaster on the home front.
Just days after I wrote to you last week to hold your shares of this biotech company in our portfolio in hopes of a reverse merger, it happened. Now we have some hope.